Amryt Pharma Holdings Ltd banner

Amryt Pharma Holdings Ltd
LSE:AMYT

Watchlist Manager
Amryt Pharma Holdings Ltd Logo
Amryt Pharma Holdings Ltd
LSE:AMYT
Watchlist
Price: 143 GBX -11.73% Market Closed
Market Cap: £457.1m

Amryt Pharma Holdings Ltd
Investor Relations

Amryt Pharma Plc is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. The firm is focused on developing and commercialization of treatments for orphan and rare diseases patients. The Company’s commercial business provides orphan disease products, which includes Juxtapid/ Lojuxta and Myalept / Myalepta. The Company’s lead development candidate is FILSUVEZ.

Show more
Loading
AMYT
FTSE All Share Index
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Joseph A. Wiley
CEO & Director
No Bio Available
Mr. Rory P. Nealon
CFO, COO & Company Sec.
No Bio Available
Ms. Elizabeth Varki Jobes J.D.
Sr. VP & Global Chief Compliance Officer
No Bio Available
Mr. John McEvoy
Gen. Counsel
No Bio Available
Mr. Stephen Joyce
VP of Global Marketing
No Bio Available
Ms. Julie Eastwood
Head of HR
No Bio Available
Ms. Derval O'Carroll
Head of Regulatory Affairs
No Bio Available
Mr. Gerry Gilligan
Head of Manufacturing Supply Chain
No Bio Available
Dr. Mark Sumeray
Chief Medical Officer
No Bio Available
Dr. Helen Phillips
Head of Medical Affairs
No Bio Available

Contacts

Address
London
Ivybridge House, 1 Adam Street
Contacts
+442034155730
www.amrytpharma.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett